Atorvastatin Affects Several Angiogenic Mediators in Human Endothelial Cells

• Published in: Endothelium (New York, N.Y.) Vol. 12; no. 5-6; pp. 233 - 241
• Main Authors: Dulak, Józef, Loboda, Agnieszka, Jazwa, Agnieszka, Zagorska, Anna, Dörler, Jacob, Alber, Hannes, Dichtl, Wolfgang, Weidinger, Franz, Frick, Matthias, Jozkowicz, Alicja
• Format: Journal Article
• Language: English
• Published: England Informa UK Ltd 01.01.2005; Taylor & Francis
• Subjects: Atherosclerosis; Atorvastatin Calcium; Cancer; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells - cytology; Endothelial Cells - metabolism; Gene Expression Regulation - drug effects; Gene Expression Regulation - genetics; Heme Oxygenase-1; Heptanoic Acids - pharmacology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology; Intercellular Signaling Peptides and Proteins - biosynthesis; Intercellular Signaling Peptides and Proteins - genetics; Interleukin 8; Neovascularization, Physiologic - drug effects; Neovascularization, Physiologic - genetics; Pyrroles - pharmacology; Vascular Endothelial Growth Factor
• DOI: 10.1080/10623320500476559
• ISSN: 1062-3329

The pleiotropic effects of statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, have been recently extended to the modulation of angiogenesis. Here, to get more insight into the statins action, the authors have investigated the effect of atorvastatin on the expression of several angiogenic and inflammatory genes in human umbilical endothelial cells (HUVECs). Atorvastatin was proangiogenic at the dose of 10 nM, and antiangiogenic at the concentrations of 1 to 10 μ M. Moreover, these higher concentrations inhibited also the proliferation of HUVECs induced by vascular endothelial growth factor (VEGF). Lower doses of atorvastatin did not influence endothelial cell proliferation. Importantly, atorvastatin at the micromolar concentrations diminished the production of interleukin (IL)-8, a proinflammatory and proangiogenic chemokine, and inhibited the synthesis of urokinase plasminogen activator (uPA), a potent proinflammatory mediator. However, it decreased also the expression of plasminogen activator inhibitor-1 (PAI-1) and thrombospondin-1 (TSP-1), the inhibitors of angiogenesis. Atorvastatin stimulated the expression of angiopoietin (Ang)-2 and moderately enhanced the expression of endothelial nitric oxide synthase (eNOS), whereas heme oxygenase-1 (HO-1) was not significantly affected. In conclusion, the present findings points to other angiogenesis-related effects of atorvastatin, which may be of relevance to the beneficial influence of statins in cardiovascular system.